Treatment patterns for genitourinary syndrome of menopause: a TriNetX analysis
Most women diagnosed with GSM did not receive treatment. Among those treated, topical estrogen was the predominant therapy. Newer therapies were underutilized, though it is unclear whether this is due to provider familiarity, patient preference, or access. Further research is warranted to elucidate the underlying reasons for undertreatment in this population.
Authors
- Whitney R. Smith
- Costas D. Lallas (ORCID: https://orcid.org/0000-0001-8937-7661)
- Mihir Shah
- Alana M Murphy (ORCID: https://orcid.org/0000-0002-3762-6379)
- Yash Shah (ORCID: https://orcid.org/0000-0003-1551-7611)
- Maria J D'Amico
- Anushka Ghosh (ORCID: https://orcid.org/0009-0001-3344-7592)
Institutions
- Thomas Jefferson University (US)
Publication Details
- Journal
- Canadian Journal of Urology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.32604/cju.2025.067575
- Primary Topic
- Menopause: Health Impacts and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00